Macular Edema Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Macular Edema stocks.

Macular Edema Stocks Recent News

Date Stock Title
May 8 EYPT EyePoint Pharmaceuticals GAAP EPS of -$0.55 misses by $0.17, revenue of $11.68M beats by $2.54M
May 8 REGN Regeneron gene therapy improves hearing in child deafness
May 8 EYPT EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments
May 8 EYPT Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
May 8 REGN Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
May 7 EYPT EyePoint Stock: NPDR Endpoint Miss Is A Buying Opportunity Based On Lead Program
May 6 REGN Regeneron Announces Investor Conference Presentations
May 6 EYPT EyePoint's Setback In NPDR Does Not Bode Well For DME (Rating Downgrade)
May 6 REGN Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks
May 6 EYPT EyePoint tumbles 30% premarket on failed Phase 2 study
May 6 EYPT Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
May 6 OCUP Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
May 6 EYPT EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYUâ„¢ in Non-Proliferative Diabetic Retinopathy
May 5 REGN Wall Street Breakfast: The Week Ahead
May 4 REGN 23 Most Profitable Stocks of the Last 12 Months
May 3 REGN Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
May 3 REGN Regeneron Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
May 3 OCUP Ocuphire Pharma to Present at the Aegis Virtual Conference
May 3 REGN Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
May 3 REGN Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
Macular Edema

Macular edema is a condition in which fluid accumulates in the macula, the part of the eye responsible for central vision. It can cause blurred vision, difficulty reading, and other vision problems. Macular edema can be caused by a variety of conditions, including diabetes, retinal vein occlusion, and uveitis. Treatment may include medications, laser therapy, or surgery.

Browse All Tags